Rubicon Organics today announced that its "Cascadia" facility, located in Hope, British Columbia, has received its license to cultivate, process, and store cannabis from Health Canada.
The license will enable Rubicon to begin cultivating cannabis at the 47,500-square-foot indoor facility. This new facility will provide an additional 4,500 kg of production capacity, representing an incremental 40% on existing capacity, bringing the company's total annual capacity to 15,500 kg of cannabis.
Operations at the Cascadia facility are now underway. The company expects first revenue in the first half of 2026.
“The receipt of this license is a significant step in the transformation of Rubicon Organics. This additional 40% capacity will allow Rubicon to meet currently unmet demand for our award-winning premium products in Canada and in additional markets.” said Margaret Brodie, CEO. “Our newly-licensed Cascadia facility will also provide us with an indoor cultivation environment in which I expect certain cannabis strains will perform well, as well as additional capacity to begin addressing the international market opportunities for premium branded Rubicon product.”
Rubicon also announced the naming of the existing Delta, B.C. and Hope, B.C. facilities, to Pacifica and Cascadia, respectively. The company said the naming reflects its legacy West Coast culture and expanded domestic and international focus.
